Literature DB >> 29651665

Evaluation and management of thromboprophylaxis in Moroccan hospitals at national level: the Avail-MoNa study.

Z Tazi Mezalek1,2, C Nejjari3, L Essadouni4, M Samkaoui5, K Serraj6, W Ammouri7,8, N Kanjaa9, Z Belkhadir10, B Housni11, M Awab12, M Faroudy13, W Bono14, S Kabbaj15, M Akkaoui16, M Barakat17, R Rifai18, H Charaf19, A Aziz20, Y Elachhab3, A Azzouzi12.   

Abstract

Venous thromboembolism (VTE) is a common clinical problem that is associated with substantial morbidity and mortality. The aim of this study was to describe the clinical practices in VTE prophylaxis in university and peripheral hospitals in Morocco. This is a national, cross-sectional, multicenter, observational study assessing the management of the VTE risk in selected Moroccan hospitals (four university and three peripheral). The thromboembolic risk of the selected patients was assessed according to the American College of Chest Physicians (ACCP) guidelines (2008). We hypothesized that interventions for VTE guideline implementation in those hospitals may improve prophylaxis use for hospitalized patients. A total of 1318 patients were analyzed: 467 (35.5%) medical and 851 (64.5%) surgical. The mean age of patients was 52.6 ± 16.5 years, and 52.7% were female. A total of 51.1% patients were considered to be at risk of VTE according to ACCP guidelines and were eligible for thromboprophylaxis (TP). Medical patients were more likely to present risk factors than surgical patients (53.6 vs. 50.7%, respectively). TP was prescribed for 53.1% of these patients, 57.4% in at-risk surgical patients and 50.3% in at-risk medical patients. TP was also prescribed for 42.9% of non-at-risk patients. The concordance between the recommended and the prescribed prophylaxis was poor for the total population (kappa = 0.110). TP did not improve sufficiently in our hospitals, even after implementation of the guidelines. New strategies are required to appropriately address TP in hospitalized patients.

Entities:  

Keywords:  Hospitalized patients; Risk assessment; Thromboprophylaxis; Venous thrombosis

Mesh:

Year:  2018        PMID: 29651665     DOI: 10.1007/s11239-018-1657-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  33 in total

1.  Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial.

Authors:  Federico Germini; Giancarlo Agnelli; Marta Fedele; Maria Giulia Galli; Michela Giustozzi; Maura Marcucci; Gloria Paganelli; Emanuele Pinotti; Cecilia Becattini
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

2.  Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers.

Authors:  Ian H Jenkins; Richard H White; Alpesh N Amin; Nasim Afsarmanesh; Andrew D Auerbach; Raman Khanna; Gregory A Maynard
Journal:  J Hosp Med       Date:  2016-12       Impact factor: 2.960

3.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

4.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

Review 5.  Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.

Authors:  Susan R Kahn; David R Morrison; Jacqueline M Cohen; Jessica Emed; Vicky Tagalakis; Andre Roussin; William Geerts
Journal:  Cochrane Database Syst Rev       Date:  2013-07-16

6.  Thromboprophylaxis use and concordance with guidelines among medical and surgical patients in Morocco.

Authors:  Tazi Mezalek Zoubida; Abderahim Azzouzi; Wafaa Bono; Rajae Tachinante; Mamoun Faroudy; Lamiaa Essaadouni; Chakib Nejjari
Journal:  Thromb Res       Date:  2014-02-04       Impact factor: 3.944

7.  Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start).

Authors:  A Amin; A C Spyropoulos; P Dobesh; A Shorr; M Hussein; E Mozaffari; J S Benner
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

8.  The implementation of NICE guidance on venous thromboembolism risk assessment and prophylaxis: a before-after observational study to assess the impact on patient safety across four hospitals in England.

Authors:  Alice G Bateman; Rod Sheaff; Susan Child; Olga Boiko; Obioha C Ukoumunne; Tim Nokes; Adrian Copplestone; Christian A Gericke
Journal:  BMC Health Serv Res       Date:  2013-06-04       Impact factor: 2.655

9.  A clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income country.

Authors:  Fernanda Fuzinatto; Fernando Starosta de Waldemar; André Wajner; Cesar Al Alam Elias; Juliana Fernándes Fernandez; João Luiz de Souza Hopf; Sergio Saldanha Menna Barreto
Journal:  J Bras Pneumol       Date:  2013 Mar-Apr       Impact factor: 2.624

10.  Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial.

Authors:  Pierre-Marie Roy; Antoine Rachas; Guy Meyer; Grégoire Le Gal; Pierre Durieux; Dominique El Kouri; Didier Honnart; Jeannot Schmidt; Catherine Legall; Pierre Hausfater; Jean-Marie Chrétien; Dominique Mottier
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more
  1 in total

1.  An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta-analysis.

Authors:  Gabor Forgo; Evy Micieli; Walter Ageno; Lana A Castellucci; Gabriela Cesarman-Maus; Henry Ddungu; Erich Vinicius De Paula; Mert Dumantepe; Maria Cecilia Guillermo Esposito; Stavros V Konstantinides; Nils Kucher; Claire McLintock; Fionnuala Ní Áinle; Alex C Spyropoulos; Tetsumei Urano; Beverley J Hunt; Stefano Barco
Journal:  J Thromb Haemost       Date:  2021-12-13       Impact factor: 16.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.